Oppenheimer & Co’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Buy
4,796
+308
+7% +$88.5K 0.02% 712
2025
Q1
$1.38M Sell
4,488
-179
-4% -$55.2K 0.02% 667
2024
Q4
$1.65M Sell
4,667
-1,581
-25% -$558K 0.02% 601
2024
Q3
$2.24M Buy
6,248
+1,078
+21% +$386K 0.03% 513
2024
Q2
$1.65M Buy
5,170
+530
+11% +$169K 0.03% 595
2024
Q1
$1.07M Buy
4,640
+699
+18% +$161K 0.02% 719
2023
Q4
$867K Buy
3,941
+505
+15% +$111K 0.02% 756
2023
Q3
$776K Sell
3,436
-3,850
-53% -$870K 0.02% 763
2023
Q2
$1.61M Buy
7,286
+722
+11% +$159K 0.03% 533
2023
Q1
$1.47M Sell
6,564
-659
-9% -$148K 0.03% 551
2022
Q4
$2.01M Sell
7,223
-2,064
-22% -$574K 0.05% 441
2022
Q3
$1.95M Buy
9,287
+2,713
+41% +$568K 0.05% 441
2022
Q2
$1.55M Buy
6,574
+3,256
+98% +$767K 0.03% 535
2022
Q1
$595K Sell
3,318
-396
-11% -$71K 0.01% 937
2021
Q4
$803K Buy
3,714
+184
+5% +$39.8K 0.01% 864
2021
Q3
$652K Buy
3,530
+670
+23% +$124K 0.01% 908
2021
Q2
$513K Sell
2,860
-214
-7% -$38.4K 0.01% 1020
2021
Q1
$514K Buy
3,074
+392
+15% +$65.5K 0.01% 954
2020
Q4
$407K Sell
2,682
-34
-1% -$5.16K 0.01% 972
2020
Q3
$274K Sell
2,716
-2,582
-49% -$260K 0.01% 1023
2020
Q2
$641K Buy
+5,298
New +$641K 0.02% 712
2020
Q1
Sell
-5,121
Closed -$451K 1332
2019
Q4
$451K Hold
5,121
0.01% 878
2019
Q3
$408K Buy
5,121
+1,267
+33% +$101K 0.01% 870
2019
Q2
$301K Buy
+3,854
New +$301K 0.01% 1005
2018
Q1
Sell
-1,616
Closed -$239K 1395
2017
Q4
$239K Buy
+1,616
New +$239K 0.01% 1144
2015
Q3
Sell
-2,055
Closed -$357K 1464
2015
Q2
$357K Buy
+2,055
New +$357K 0.01% 1026
2014
Q3
Sell
-4,187
Closed -$371K 1492
2014
Q2
$371K Buy
+4,187
New +$371K 0.01% 970
2013
Q3
Sell
-27,960
Closed -$1.84M 1368
2013
Q2
$1.84M Buy
+27,960
New +$1.84M 0.07% 324